<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Einstein (Sao Paulo)</journal-id>
      <journal-id journal-id-type="iso-abbrev">Einstein (Sao Paulo)</journal-id>
      <journal-title-group>
        <journal-title>Einstein</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1679-4508</issn>
      <issn pub-type="epub">2317-6385</issn>
      <publisher>
        <publisher-name>Instituto Israelita de Ensino e Pesquisa Albert Einstein</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25628206</article-id>
      <article-id pub-id-type="pmc">4879921</article-id>
      <article-id pub-id-type="publisher-id">S1679-45082014RC2745</article-id>
      <article-id pub-id-type="doi">10.1590/S1679-45082014RC2745</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Primary hepatic carcinoid tumor: case report and literature review</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Camargo</surname>
            <given-names>&#xC9;den Sartor</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Viveiros</surname>
            <given-names>Marcelo de Melo</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Corr&#xEA;a</surname>
            <given-names>Isaac Jos&#xE9; Felippe</given-names>
            <suffix>Neto</suffix>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Robles</surname>
            <given-names>Laercio</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rezende</surname>
            <given-names>Marcelo Bruno</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>1</label>Hospital Santa Marcelina, S&#xE3;o Paulo, SP, Brazil.</aff>
      <author-notes>
        <corresp>Corresponding author: &#xC9;den Sartor Camargo &#x2212; Avenida Marcos Konder, 1111 &#x2212; Centro &#x2212; Zip code: 88301-303 &#x2212; Itaja&#xED;, SC, Brazil &#x2212; Phone: (55 47) 3249-9400 &#x2212; E-mail: <email>edensc@terra.com.br</email></corresp>
      </author-notes>
      <pub-date pub-type="epub-ppub">
        <season>Oct-Dec</season>
        <year>2014</year>
      </pub-date>
      <!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
      <pub-date pub-type="ppub">
        <season>Oct-Dec</season>
        <year>2014</year>
      </pub-date>
      <volume>12</volume>
      <issue>4</issue>
      <fpage>505</fpage>
      <lpage>508</lpage>
      <history>
        <date date-type="received">
          <day>8</day>
          <month>3</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>30</day>
          <month>12</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
          <license-p>This work is licensed under a Creative Commons Attribution 4.0 International License.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Primary hepatic carcinoid tumors are extremely rare neoplasms derived from hormone-producing neuroendocrine cells. It is difficult to make their diagnosis before biopsy, surgical resection or necropsy. A recent publication described only 94 cases of these tumors. There is no sex predilection and apparently it has no association with cirrhosis or preexisting hepatic disease. The most effective treatment is hepatectomy, and resection is determined by size and location of the lesions.</p>
      </abstract>
      <kwd-group>
        <kwd>Liver neoplasms</kwd>
        <kwd>Neuroendocrine tumors/diagnosis</kwd>
        <kwd>Carcinoid tumor</kwd>
        <kwd>Case reports</kwd>
      </kwd-group>
      <counts>
        <fig-count count="8"/>
        <table-count count="0"/>
        <equation-count count="0"/>
        <ref-count count="18"/>
        <page-count count="4"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>The liver is the organ most often affected by metastases of neuroendocrine tumors,<sup>(<xref rid="B1" ref-type="bibr">1</xref>-<xref rid="B3" ref-type="bibr">3</xref>)</sup> but the primary hepatic carcinoid tumors are extremely rare. Only 60 cases had been described up to 2008<sup>(<xref rid="B4" ref-type="bibr">4</xref>)</sup> and 94 cases were reported in a recent publication. Carcinoid tumors were first reported by Lubarsch, in 1888,<sup>(<xref rid="B5" ref-type="bibr">5</xref>)</sup> and are functional neoplasms that can develop in any part of the body. However, approximately 54% to 90% of the cases originate from the gastrointestinal tract,<sup>(<xref rid="B6" ref-type="bibr">6</xref>,<xref rid="B7" ref-type="bibr">7</xref>)</sup> mainly from the appendix, small bowel and rectum.</p>
      <p>The primary hepatic carcinoid tumors are neoplasms derived from hormone-producing neuroendocrine cells, especially serotonin. Since they are very rare, it is difficult to make their diagnosis before biopsy, surgical resection or even necropsy.<sup>(<xref rid="B8" ref-type="bibr">8</xref>)</sup> There is no sex predilection and the tumors affect individuals aged between 40 and 50 years.<sup>(<xref rid="B9" ref-type="bibr">9</xref>)</sup> The cases reported present large tumors in the hepatic parenchyma, with non-specific and mild symptoms. Due to fast progression of the tumor and delay in making diagnosis, very few cases are surgically resectable.<sup>(<xref rid="B10" ref-type="bibr">10</xref>)</sup>
</p>
      <p>The primary carcinoid tumor of the liver was first described by Edmonsdson, in 1958, and its origin remains uncertain.<sup>(<xref rid="B11" ref-type="bibr">11</xref>)</sup> The mutating cells originate from the ectopic pancreatic or adrenal tissue in the hepatic parenchyma, or from neuroendocrine cells located in the intrahepatic biliary epithelium.<sup>(<xref rid="B12" ref-type="bibr">12</xref>)</sup> Moreover, it was proposed that the chronic inflammation of the bile canaliculi can cause intestinal metaplasia, which predisposes the development of neuroendocrine tumors.<sup>(<xref rid="B12" ref-type="bibr">12</xref>)</sup> The primary hepatic carcinoid tumor has no association with cirrhosis or preexisting liver disease<sup>(<xref rid="B4" ref-type="bibr">4</xref>) </sup>and accounts to only 0.3% of the cases of neuroendocrine tumors.<sup>(<xref rid="B7" ref-type="bibr">7</xref>)</sup>
</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>A 34-year-old male patient referred abdominal pain that was intermittent, progressive, related to compression on the right flank and irradiating to the dorsum and ipsilateral shoulder, for three months. He presented postprandial fullness, constipation and weight loss (3% of body weight).</p>
      <p>The laboratory test results showed normal complete blood count and liver function tests, negative serology for hepatites, slight increase in canalicular enzymes and tumor markers within normalcy. Abdominal ultrasound showed a heterogeneous mass in the right hepatic lobe measuring 12x10cm, with a solid-cystic content. Computed tomography demonstrated enlarged liver due to the right hepatic lobe that presented an extensive infiltrating lesion with poorly-defined contours, a liquefied center and the periphery was partially enhanced by contrast medium. There was no further involvement of other organs (<xref ref-type="fig" rid="f01">Figure 1A</xref> and <xref ref-type="fig" rid="f01">B</xref>).</p>
      <p>
<fig id="f01" orientation="portrait" position="float"><label>Figure 1</label><caption><title>(A) Axial computed tomography image - portal phase - middle hepatic vein - contact with lesion. (B) Coronal computed tomography image</title></caption><graphic xlink:href="1679-4508-eins-12-4-0505-gf01"/></fig>
</p>
      <p>The patient was submitted to ultrasound-guided percutaneous liver biopsy. The pathologic report described neoplasm of undetermined histogenesis, suggesting carcinoid tumor, and immunohistochemistry confirmed the diagnosis. The investigation was complemented with OctreoScan<sup>&#xAE;</sup> that specifically demonstrated a primary hepatic carcinoid tumor (<xref ref-type="fig" rid="f02">Figure 2</xref>).</p>
      <p>
<fig id="f02" orientation="portrait" position="float"><label>Figure 2</label><caption><title>Octreotide scintigraphy shows radiomarker uptake in hepatic lesion</title></caption><graphic xlink:href="1679-4508-eins-12-4-0505-gf02"/></fig>
</p>
      <p>He underwent right hepatectomy, and an irregular extensive lesion occupying the whole right lobe was evident in the intraoperative period (<xref ref-type="fig" rid="f03">Figure 3</xref>). The patient progressed well and was discharged on postoperative day 7. The pathological examination showed a malignant neoplasm with neuroendocrine differentiation and positive immunohistochemistry for synaptofisin, vimentin, chromogranin and KI-67, thus confirming the diagnosis of primary hepatic carcinoid tumor (<xref ref-type="fig" rid="f04">Figure 4</xref>).</p>
      <p>
<fig id="f03" orientation="portrait" position="float"><label>Figure 3</label><caption><title>Liver with extensive lesion in the right lobe</title></caption><graphic xlink:href="1679-4508-eins-12-4-0505-gf03"/></fig>
</p>
      <p>
<fig id="f04" orientation="portrait" position="float"><label>Figure 4</label><caption><title>Histology &#x2013; epithelioid neoplasm, with medium-sized cells, irregular nuclei, in organoid arrangements and blocks - 8 mitosis per 10 HPF, with necrotic foci</title></caption><graphic xlink:href="1679-4508-eins-12-4-0505-gf04"/></fig>
</p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>Primary hepatic carcinoid tumor may be an incidental finding or it may present with abdominal pain, jaundice, a palpable mass in the upper right quadrant of the abdomen, weight loss, Cushing syndrome and carcinoid syndrome.<sup>(<xref rid="B4" ref-type="bibr">4</xref>,<xref rid="B13" ref-type="bibr">13</xref>)</sup> There is usually liver metastasis when carcinoid syndrome occurs (facial redness, abdominal pain and diarrhea). This clinical picture is very rare, and there are only two cases described in the medical literature.<sup>(<xref rid="B8" ref-type="bibr">8</xref>,<xref rid="B14" ref-type="bibr">14</xref>)</sup>
</p>
      <p>The investigation should first include an abdominal ultrasound, which often demonstrates a solid-cystic tumor.<sup>(<xref rid="B2" ref-type="bibr">2</xref>)</sup> Further workup with computed tomography generally corroborates the ultrasonographic findings. It is difficult to make a definite diagnosis primarily due to its similarity to hepatocellular carcinoma. Finally, OctreoScan<sup>&#xAE;</sup> is very useful and its specificity achieves up to 83%.<sup>(<xref rid="B15" ref-type="bibr">15</xref>)</sup>
</p>
      <p>Histopathology reveals a malignant neoplasm, with neuroendocrine differentiation and eight mitotic figures per high-power field, but it is not specific for diagnosis of primary hepatic carcinoid tumor, according to the literature.<sup>(<xref rid="B2" ref-type="bibr">2</xref>)</sup> In the present study, immunohistochemistry correlated with the literature and showed positive chromogranin in 89.1%, and synaptofisin in 55% of the cases.<sup>(<xref rid="B8" ref-type="bibr">8</xref>)</sup>
</p>
      <p>The most effective treatment is hepatectomy.<sup>(<xref rid="B4" ref-type="bibr">4</xref>)</sup> Survival rate may increase from 29% to 78%.<sup>(<xref rid="B5" ref-type="bibr">5</xref>)</sup> Systemic chemotherapy or chemoembolization showed uncertain results.<sup>(<xref rid="B2" ref-type="bibr">2</xref>)</sup> The indication of liver transplant remains a dilemma, and some researchers suggest this therapy for patients with multiple lesions or in cases of disease with impaired liver function.<sup>(<xref rid="B16" ref-type="bibr">16</xref>)</sup> Another possible treatment is radiofrequency.<sup>(<xref rid="B4" ref-type="bibr">4</xref>)</sup>
</p>
      <p>Recent studies reported a five-year survival of 74-78% in patients submitted to hepatectomy, and the recurrence rate was approximately 18%.<sup>(<xref rid="B17" ref-type="bibr">17</xref>,<xref rid="B18" ref-type="bibr">18</xref>)</sup> According to Schwartz et al.,<sup>(<xref rid="B4" ref-type="bibr">4</xref>) </sup>the distant metastases are not described when there is no hepatic involvement.</p>
      <p>Up to 2009, in the largest series published in the literature, Lin et al.<sup>(<xref rid="B8" ref-type="bibr">8</xref>)</sup> reported 94 cases and described abdominal pain as the most frequent symptom (44% of cases), followed by abdominal mass (14.3%) and absence of symptoms (13.1%); unilobar location (76.6%) and single lesion (62,8%). Hepatectomy was performed in 86.8% of their patients, and overall mortality was 25.5%.</p>
      <p>Huang et al.<sup>(<xref rid="B2" ref-type="bibr">2</xref>)</sup> are the authors of the largest series from a single center, describing 11 cases of primary hepatic carcinoid tumor within a 13-year period of analysis.</p>
    </sec>
    <sec sec-type="conclusions">
      <title>CONCLUSION</title>
      <p>Carcinoid tumors with liver metastasis are relatively common. However, the primary involvement of this organ is very rare. Better diagnostic methods are required to make a more precise preoperative differentiation between primary hepatic carcinoid tumor and hepatocellular carcinoma.</p>
      <p>Primary hepatic carcinoid tumor should be suspected in patients with no chronic liver disease, normal alpha-fetoprotein levels and solid-cystic lesion in imaging tests, associated with diarrhea and abdominal pain.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>REFER&#xCA;NCIAS</title>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fernandes</surname>
              <given-names>LC</given-names>
            </name>
            <name>
              <surname>Pucca</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Matos</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title xml:lang="pt">Diagn&#xF3;stico e tratamento de tumores carcinoides do trato digestivo</article-title>
          <source>Rev Assoc Med Bras</source>
          <year>2002</year>
          <volume>48</volume>
          <issue>1</issue>
          <fpage>87</fpage>
          <lpage>92</lpage>
          <pub-id pub-id-type="pmid">12185641</pub-id>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Huang</surname>
              <given-names>YO</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Primary hepatic neuroendocrine carcinoma:clinical analysis of 11 cases</article-title>
          <source>Hepatobiliary Pancreas Dis Int</source>
          <year>2010</year>
          <volume>9</volume>
          <issue>1</issue>
          <fpage>44</fpage>
          <lpage>48</lpage>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Maggard</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>O&#xB4;Connell</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Ko</surname>
              <given-names>CY</given-names>
            </name>
          </person-group>
          <article-title>Update population based review of carcinoid tumors</article-title>
          <source>Ann Surg</source>
          <year>2004</year>
          <volume>240</volume>
          <issue>1</issue>
          <fpage>117</fpage>
          <lpage>122</lpage>
          <pub-id pub-id-type="pmid">15213627</pub-id>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schwartz</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Colanta</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Gaetz</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Olichney</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Attiyeh</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Primary carcinoid tumor of the liver</article-title>
          <source>World J Surg Oncol</source>
          <year>2008</year>
          <volume>6</volume>
          <issue>91</issue>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lubarsch</surname>
              <given-names>O</given-names>
            </name>
          </person-group>
          <article-title xml:lang="de">Uberdenprim&#xE4;eren Krebs desileum, nebstbemerkungen&#xFC;ber das gleichzeitigevorkommenvonkrebsund tuberculose</article-title>
          <source>Virchows Arch</source>
          <year>1888</year>
          <volume>111</volume>
          <fpage>280</fpage>
          <lpage>370</lpage>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Caplin</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Buscombe</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Hilson</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Watkinson</surname>
              <given-names>AF</given-names>
            </name>
            <name>
              <surname>Burroughs</surname>
              <given-names>AK</given-names>
            </name>
          </person-group>
          <article-title>Carcinoid tumor</article-title>
          <source>Lancet</source>
          <year>1998</year>
          <volume>352</volume>
          <issue>9130</issue>
          <fpage>799</fpage>
          <lpage>805</lpage>
          <pub-id pub-id-type="pmid">9737302</pub-id>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fenoglio</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Severini</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ferrigno</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Goll&#xE8;</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Serraino</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Bracco</surname>
              <given-names>C</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Primary hepatic carcinoid: a case report and literature review</article-title>
          <source>World J Gastroenterol</source>
          <year>2009</year>
          <volume>15</volume>
          <issue>19</issue>
          <fpage>2418</fpage>
          <lpage>2422</lpage>
          <pub-id pub-id-type="pmid">19452590</pub-id>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lin</surname>
              <given-names>CW</given-names>
            </name>
            <name>
              <surname>Lai</surname>
              <given-names>CH</given-names>
            </name>
            <name>
              <surname>Hsu</surname>
              <given-names>CC</given-names>
            </name>
            <name>
              <surname>Hsu</surname>
              <given-names>CT</given-names>
            </name>
            <name>
              <surname>Hsieh</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Hung</surname>
              <given-names>KC</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Primary hepatic carcinoid tumor: a case report and review of the literature</article-title>
          <source>Cases J</source>
          <year>2009</year>
          <volume>2</volume>
          <issue>1</issue>
          <size units="pages">90</size>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Modlin</surname>
              <given-names>IM</given-names>
            </name>
            <name>
              <surname>Kidd</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Latich</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Zikusoba</surname>
              <given-names>MN</given-names>
            </name>
            <name>
              <surname>Shapiro</surname>
              <given-names>MD</given-names>
            </name>
          </person-group>
          <article-title>Current status of gastrointestinal carcinoids</article-title>
          <source>Gastroenterology</source>
          <year>2005</year>
          <volume>128</volume>
          <issue>6</issue>
          <fpage>1717</fpage>
          <lpage>1751</lpage>
          <pub-id pub-id-type="pmid">15887161</pub-id>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Paula</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Gon&#xE7;alves</surname>
              <given-names>JP</given-names>
            </name>
          </person-group>
          <article-title xml:lang="pt">Carcinoma neuroend&#xF3;crino prim&#xE1;rio de f&#xED;gado</article-title>
          <source>Rev Med Ana Costa</source>
          <year>2007</year>
          <volume>12</volume>
          <issue>2</issue>
          <fpage>57</fpage>
          <lpage>58</lpage>
        </element-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Edmondson</surname>
              <given-names>HA</given-names>
            </name>
          </person-group>
          <article-title>Differential diagnosis of tumors and tumor-like lesions of liver in infancy and childhood</article-title>
          <source>AMA J Dis Child</source>
          <year>1956</year>
          <volume>91</volume>
          <issue>2</issue>
          <fpage>168</fpage>
          <lpage>186</lpage>
          <pub-id pub-id-type="pmid">13282629</pub-id>
        </element-citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gravante</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Liguori Carino</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Overton</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Manzia</surname>
              <given-names>TM</given-names>
            </name>
            <name>
              <surname>Orlando</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Primary carcinoids of the liver: a review of symptoms, diagnosis and treatments</article-title>
          <source>Dig Surg</source>
          <year>2008</year>
          <volume>25</volume>
          <issue>5</issue>
          <fpage>364</fpage>
          <lpage>368</lpage>
          <pub-id pub-id-type="pmid">18984960</pub-id>
        </element-citation>
      </ref>
      <ref id="B13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shah</surname>
              <given-names>NA</given-names>
            </name>
            <name>
              <surname>Urusova</surname>
              <given-names>IA</given-names>
            </name>
            <name>
              <surname>D&#x2019;Agnolo</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Colquhoun</surname>
              <given-names>SD</given-names>
            </name>
            <name>
              <surname>Rosenbloom</surname>
              <given-names>BE</given-names>
            </name>
            <name>
              <surname>Vener</surname>
              <given-names>SL</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Primary hepatic carcinoid tumor presenting as Cushing&#xB4;s syndrome</article-title>
          <source>J Endocrinol Invest</source>
          <year>2007</year>
          <volume>30</volume>
          <issue>4</issue>
          <fpage>327</fpage>
          <lpage>333</lpage>
          <pub-id pub-id-type="pmid">17556871</pub-id>
        </element-citation>
      </ref>
      <ref id="B14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tohyama</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Matsui</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kitagawa</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Primary hepatic carcinoid tumor with carcinoid syndrome and carcinoid heart disease: a case report of patient on long-term follow-up</article-title>
          <source>Intern Med</source>
          <year>2005</year>
          <volume>44</volume>
          <issue>9</issue>
          <fpage>958</fpage>
          <lpage>962</lpage>
          <pub-id pub-id-type="pmid">16258211</pub-id>
        </element-citation>
      </ref>
      <ref id="B15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oberg</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Eriksson</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Nuclear medicine in the detection, staging and treatment of gastrointestinal carcinoid tumours</article-title>
          <source>Best Pract Res Clin Endocrinol Metab</source>
          <year>2005</year>
          <volume>19</volume>
          <issue>2</issue>
          <fpage>265</fpage>
          <lpage>276</lpage>
          <pub-id pub-id-type="pmid">15763700</pub-id>
        </element-citation>
      </ref>
      <ref id="B16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fenwick</surname>
              <given-names>SW</given-names>
            </name>
            <name>
              <surname>Wyatt</surname>
              <given-names>JI</given-names>
            </name>
            <name>
              <surname>Toogood</surname>
              <given-names>GJ</given-names>
            </name>
            <name>
              <surname>Lodge</surname>
              <given-names>JP</given-names>
            </name>
          </person-group>
          <article-title>Hepatic resection and transplantation for primary carcinoid tumors of the liver</article-title>
          <source>Ann Surg</source>
          <year>2004</year>
          <volume>239</volume>
          <issue>2</issue>
          <fpage>210</fpage>
          <lpage>219</lpage>
          <pub-id pub-id-type="pmid">14745329</pub-id>
        </element-citation>
      </ref>
      <ref id="B17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mizuno</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Ohkohchi</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Fujimori</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Doi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Orii</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Asakura</surname>
              <given-names>T</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Primary hepatic carcinoid tumor: a case report</article-title>
          <source>Hepatogastroenterology</source>
          <year>2000</year>
          <volume>47</volume>
          <issue>32</issue>
          <fpage>528</fpage>
          <lpage>530</lpage>
          <pub-id pub-id-type="pmid">10791229</pub-id>
        </element-citation>
      </ref>
      <ref id="B18">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Knox</surname>
              <given-names>CD</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>CD</given-names>
            </name>
            <name>
              <surname>Lamps</surname>
              <given-names>LW</given-names>
            </name>
            <name>
              <surname>Adkins</surname>
              <given-names>RB</given-names>
            </name>
            <name>
              <surname>Pinson</surname>
              <given-names>CW</given-names>
            </name>
          </person-group>
          <article-title>Long term survival after resection for primary hepatic carcinoid tumor</article-title>
          <source>Ann Surg Oncol</source>
          <year>2003</year>
          <volume>10</volume>
          <issue>10</issue>
          <fpage>1171</fpage>
          <lpage>1175</lpage>
          <pub-id pub-id-type="pmid">14654473</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article id="TRen" article-type="translation" xml:lang="pt">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Relato De Caso</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Tumor neuroend&#xF3;crino prim&#xE1;rio do f&#xED;gado: descri&#xE7;&#xE3;o de caso e revis&#xE3;o da literatura</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Camargo</surname>
            <given-names>&#xC9;den Sartor</given-names>
          </name>
          <xref ref-type="aff" rid="aff1002">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Viveiros</surname>
            <given-names>Marcelo de Melo</given-names>
          </name>
          <xref ref-type="aff" rid="aff1002">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Corr&#xEA;a</surname>
            <given-names>Isaac Jos&#xE9; Felippe</given-names>
            <suffix>Neto</suffix>
          </name>
          <xref ref-type="aff" rid="aff1002">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Robles</surname>
            <given-names>Laercio</given-names>
          </name>
          <xref ref-type="aff" rid="aff1002">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rezende</surname>
            <given-names>Marcelo Bruno</given-names>
          </name>
          <xref ref-type="aff" rid="aff1002">
            <sup>1</sup>
          </xref>
        </contrib>
      </contrib-group>
      <aff id="aff1002"><label>1</label>Hospital Santa Marcelina, S&#xE3;o Paulo, SP, Brasil.</aff>
      <author-notes>
        <corresp>Autor correspondente: &#xC9;den Sartor Camargo &#x2212; Avenida Marcos Konder, 1111 &#x2212; Centro &#x2212; CEP: 88301-303 &#x2212; Itaja&#xED;, SC, Brasil &#x2212; Tel.: (47) 3249-9400 &#x2212; E-mail: <email>edensc@terra.com.br</email></corresp>
      </author-notes>
      <abstract>
        <p>Tumores carcinoides prim&#xE1;rios do f&#xED;gado s&#xE3;o neoplasias derivadas de c&#xE9;lulas neuroend&#xF3;crinas produtoras de horm&#xF4;nios, extremamente raras e de dif&#xED;cil diagn&#xF3;stico antes da bi&#xF3;psia, ressec&#xE7;&#xE3;o cir&#xFA;rgica ou mesmo da necr&#xF3;psia. Em recente publica&#xE7;&#xE3;o, descreveram-se apenas 94 casos dessa afec&#xE7;&#xE3;o. &#xC9; uma doen&#xE7;a sem predile&#xE7;&#xE3;o por sexo e que, aparentemente, n&#xE3;o tem associa&#xE7;&#xE3;o com cirrose, nem com doen&#xE7;a hep&#xE1;tica preexistente. O tratamento que se demonstra mais eficaz &#xE9; a hepatectomia, cuja extens&#xE3;o da ressec&#xE7;&#xE3;o &#xE9; determinada pelo tamanho e pela localiza&#xE7;&#xE3;o das les&#xF5;es.</p>
      </abstract>
      <kwd-group>
        <kwd>Neoplasias do f&#xED;gado</kwd>
        <kwd>Tumores neuroend&#xF3;crinos/diagn&#xF3;stico</kwd>
        <kwd>Tumor carcinoide</kwd>
        <kwd>Relatos de casos</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <sec>
        <title>INTRODU&#xC7;&#xC3;O</title>
        <p>Apesar de o f&#xED;gado ser o principal &#xF3;rg&#xE3;o acometido por met&#xE1;stases dos tumores carcinoides,<sup>(<xref rid="B1" ref-type="bibr">1</xref>-<xref rid="B3" ref-type="bibr">3</xref>)</sup> os carcinoides prim&#xE1;rios desse &#xF3;rg&#xE3;o s&#xE3;o extremamente raros, com descri&#xE7;&#xE3;o de apenas 60 casos at&#xE9; o ano de 2008<sup>(<xref rid="B4" ref-type="bibr">4</xref>)</sup> e de 94 casos em publica&#xE7;&#xE3;o mais recente. Inicialmente reportado por Lubarsch em 1888,<sup>(<xref rid="B5" ref-type="bibr">5</xref>)</sup> os tumores carcinoides s&#xE3;o neoplasias funcionais que podem se desenvolver em qualquer parte do corpo. Entretanto, cerca de 54 a 90% dos casos t&#xEA;m sua origem no trato gastrintestinal,<sup>(<xref rid="B6" ref-type="bibr">6</xref>,<xref rid="B7" ref-type="bibr">7</xref>)</sup> principalmente no ap&#xEA;ndice cecal, intestino delgado e reto.</p>
        <p>Os tumores neuroend&#xF3;crinos prim&#xE1;rios do f&#xED;gado (TNPF) s&#xE3;o neoplasias derivadas de c&#xE9;lulas neuroend&#xF3;crinas produtoras de horm&#xF4;nios, notadamente a serotonina, que, principalmente por sua raridade, os tornam de dif&#xED;cil diagn&#xF3;stico antes da bi&#xF3;psia, ressec&#xE7;&#xE3;o cir&#xFA;rgica ou mesmo da necropsia.<sup>(<xref rid="B8" ref-type="bibr">8</xref>)</sup> N&#xE3;o apresentam predile&#xE7;&#xE3;o por sexo e acometem indiv&#xED;duos na faixa et&#xE1;ria entre 40 e 50 anos.<sup>(<xref rid="B9" ref-type="bibr">9</xref>)</sup> Os casos relatados se apresentam como tumora&#xE7;&#xF5;es de grandes dimens&#xF5;es no par&#xEA;nquima hep&#xE1;tico, com sintomas inespec&#xED;ficos e frustos, tornando ainda mais raros os casos pass&#xED;veis de ressec&#xE7;&#xE3;o cir&#xFA;rgica, devido &#xE0; r&#xE1;pida progress&#xE3;o tumoral e &#xE0; demora no diagn&#xF3;stico.<sup>(<xref rid="B10" ref-type="bibr">10</xref>)</sup>
</p>
        <p>O TNPF foi inicialmente descrito por Edmonsdson no ano de 1958 e sua origem ainda permanece incerta.<sup>(<xref rid="B11" ref-type="bibr">11</xref>)</sup> As c&#xE9;lulas mutantes originam-se de tecido ect&#xF3;pico pancre&#xE1;tico ou adrenal encontrado no par&#xEA;nquima hep&#xE1;tico ou, ent&#xE3;o, de c&#xE9;lulas neuroend&#xF3;crinas localizadas no epit&#xE9;lio biliar intra-hep&#xE1;tico.<sup>(<xref rid="B12" ref-type="bibr">12</xref>)</sup> Al&#xE9;m disso, tamb&#xE9;m &#xE9; proposto que a inflama&#xE7;&#xE3;o cr&#xF4;nica dos canal&#xED;culos biliares pode acarretar metaplasia intestinal, a qual predisp&#xF5;e ao desenvolvimento do tumor neuroend&#xF3;crino.<sup>(<xref rid="B12" ref-type="bibr">12</xref>)</sup> O TNPF n&#xE3;o apresenta associa&#xE7;&#xE3;o com cirrose ou doen&#xE7;a hep&#xE1;tica preexistente<sup>(<xref rid="B4" ref-type="bibr">4</xref>) </sup>e corresponde a apenas de 0,3% dos casos de tumores carcinoides.<sup>(<xref rid="B7" ref-type="bibr">7</xref>)</sup>
</p>
      </sec>
      <sec>
        <title>RELATO DE CASO</title>
        <p>Paciente masculino de 34 anos de idade, com relato de dor abdominal h&#xE1; 3 meses, intermitente, progressiva, de car&#xE1;ter compressivo, em flanco direito, com irradia&#xE7;&#xE3;o para o dorso e ombro ipsilateral. Apresentava plenitude p&#xF3;s-prandial, constipa&#xE7;&#xE3;o intestinal e perda ponderal de 3% do peso corp&#xF3;reo.</p>
        <p>Possu&#xED;a hemograma e exames de fun&#xE7;&#xE3;o hep&#xE1;tica normais, sorologias negativas para hepatites, aumento discreto das enzimas canaliculares e marcadores tumorais dentro da normalidade. A ultrassonografia abd<email>ominal</email> evidenciava uma massa heterog&#xEA;nea em lobo hep&#xE1;tico direito de 12x10cm, com componente s&#xF3;lido-c&#xED;stico, e a tomografia computadorizada, f&#xED;gado com dimens&#xF5;es aumentadas &#xE0;s custas do lobo hep&#xE1;tico direito, apresentando extensa les&#xE3;o infiltrativa com contornos mal definidos, com centro liquefeito e periferia parcialmente real&#xE7;ada ao meio de contraste, al&#xE9;m de aus&#xEA;ncia de comprometimentos de outros &#xF3;rg&#xE3;os (<xref ref-type="fig" rid="f1002">Figura 1 A</xref> e <xref ref-type="fig" rid="f1002">B</xref>).</p>
        <p>
<fig id="f1002" orientation="portrait" position="float"><label>Figura 1</label><caption><title>(A) Tomografia computadorizada - corte axial - fase portal - veia hep&#xE1;tica media - contato com a les&#xE3;o. (B) Tomografia computadorizada - corte coronal</title></caption><graphic xlink:href="1679-4508-eins-12-4-0505-gf01-pt"/></fig>
</p>
        <p>O paciente foi submetido &#xE0; bi&#xF3;psia hep&#xE1;tica percut&#xE2;nea guiada por ultrassonografia. O laudo histopatol&#xF3;gico demonstrou tratar-se de neoplasia de histog&#xEA;nese indeterminada, sugerindo tumor carcinoide, e a imuno-histoqu&#xED;mica comprovou o diagn&#xF3;stico sugerido. Investiga&#xE7;&#xE3;o complementada com OctreoScan<sup>&#xAE;</sup> demostrou tratar-se especificamente de um TNPF (<xref ref-type="fig" rid="f2002">Figura 2</xref>).</p>
        <p>
<fig id="f2002" orientation="portrait" position="float"><label>Figura 2</label><caption><title>Cintilografia com ocreotide - evidenciando capta&#xE7;&#xE3;o de radiofarmaco em les&#xE3;o hep&#xE1;tica</title></caption><graphic xlink:href="1679-4508-eins-12-4-0505-gf02-pt"/></fig>
</p>
        <p>Realizada hepatectomia direita regrada, com evid&#xEA;ncia, no intraoperat&#xF3;rio, de extensa les&#xE3;o irregular que ocupava todo lobo hep&#xE1;tico direito (<xref ref-type="fig" rid="f3002">Figura 3</xref>). O paciente apresentou boa evolu&#xE7;&#xE3;o e alta hospitalar no 7&#xBA; dia. A anatomopatologia demonstrou se tratar de neoplasia maligna com diferencia&#xE7;&#xE3;o neuroend&#xF3;crina e imuno-histoqu&#xED;mica positiva para sinaptofisina, vimentina, cromogranina e KI-67, confirmando o diagn&#xF3;stico de TNPF (<xref ref-type="fig" rid="f4002">Figura 4</xref>).</p>
        <p>
<fig id="f3002" orientation="portrait" position="float"><label>Figura 3</label><caption><title>F&#xED;gado com les&#xE3;o extensa acometendo lobo hep&#xE1;tico direito</title></caption><graphic xlink:href="1679-4508-eins-12-4-0505-gf03-pt"/></fig>
</p>
        <p>
<fig id="f4002" orientation="portrait" position="float"><label>Figura 4</label><caption><title>Histologia - neoplasia epiteli&#xF3;ide com c&#xE9;lulas de tamanho intermedi&#xE1;rio, nucleos irregulares, dispostas em arranjos organ&#xF3;ides e blocos - 8 mitoses por 10 cga com focos de necrose</title></caption><graphic xlink:href="1679-4508-eins-12-4-0505-gf04-pt"/></fig>
</p>
      </sec>
      <sec>
        <title>DISCUSS&#xC3;O</title>
        <p>O TNPF pode ser um achado incidental ou, ent&#xE3;o, apresentar-se com sintomas de dor abdominal, icter&#xED;cia, massa palp&#xE1;vel em quadrante superior direito do abdome, perda ponderal, s&#xED;ndrome de Cushing e s&#xED;ndrome carcinoide.<sup>(<xref rid="B4" ref-type="bibr">4</xref>,<xref rid="B13" ref-type="bibr">13</xref>)</sup> Quando ocorre a s&#xED;ndrome carcinoide (rubor facial, dor abdominal e diarreia), geralmente h&#xE1; met&#xE1;stase hep&#xE1;tica. Essa apresenta&#xE7;&#xE3;o cl&#xED;nica &#xE9; bastante rara, com descri&#xE7;&#xE3;o de apenas dois casos na literatura.<sup>(<xref rid="B8" ref-type="bibr">8</xref>,<xref rid="B14" ref-type="bibr">14</xref>)</sup>
</p>
        <p>A investiga&#xE7;&#xE3;o deve se iniciar com ultrassonografia abdominal, que demonstra, na maioria das vezes, um tumor s&#xF3;lido-c&#xED;stico.<sup>(<xref rid="B2" ref-type="bibr">2</xref>)</sup> A proped&#xEA;utica adicional com tomografia computadorizada de abdome geralmente corrobora os achados ultrassonogr&#xE1;ficos. Al&#xE9;m disso, ressalta-se a dificuldade em se estabelecer o diagn&#xF3;stico definitivo devido, principalmente, &#xE0; sua similaridade com o carcinoma hepatocelular. Finalmente, o aux&#xED;lio do OctreoScan<sup>&#xAE;</sup> &#xE9; bastante ben&#xE9;fico, apresentando especificidade que chega a 83%.<sup>(<xref rid="B15" ref-type="bibr">15</xref>)</sup>
</p>
        <p>A histopatologia revelava se tratar de neoplasia maligna, com diferencia&#xE7;&#xE3;o neuroend&#xF3;crina, com oito figuras de mitose por campo de grande aumento e, assim como dados da literatura, n&#xE3;o &#xE9; espec&#xED;fica para o diagn&#xF3;stico de TNPF.<sup>(<xref rid="B2" ref-type="bibr">2</xref>)</sup> A imuno-histoqu&#xED;mica, no presente estudo, demonstrou correla&#xE7;&#xE3;o com a literatura, evidenciando a positividade da cromogranina em 89,1% e sinaptofisina em 55% dos casos.<sup>(<xref rid="B8" ref-type="bibr">8</xref>)</sup>
</p>
        <p>O tratamento mais eficaz &#xE9; a hepatectomia.<sup>(<xref rid="B4" ref-type="bibr">4</xref>)</sup> H&#xE1; possibilidade de aumento de sobrevida de 29% para at&#xE9; 78%.<sup>(<xref rid="B5" ref-type="bibr">5</xref>)</sup> Quimioterapia sist&#xEA;mica ou quimioemboliza&#xE7;&#xE3;o mostraram resultados incertos.<sup>(<xref rid="B2" ref-type="bibr">2</xref>)</sup> A indica&#xE7;&#xE3;o do transplante hep&#xE1;tico ainda &#xE9; um dilema, sendo que algumas pesquisas sugerem essa terapia em pacientes com m&#xFA;ltiplas les&#xF5;es ou em casos de doen&#xE7;a hep&#xE1;tica com fun&#xE7;&#xE3;o prejudicada.<sup>(<xref rid="B16" ref-type="bibr">16</xref>)</sup> Outra possibilidade terap&#xEA;utica &#xE9; a utiliza&#xE7;&#xE3;o de radiofrequ&#xEA;ncia.<sup>(<xref rid="B4" ref-type="bibr">4</xref>)</sup>
</p>
        <p>Recentes trabalhos demonstraram sobrevida de 5 anos em 74 a 78% dos casos de pacientes submetidos a hepatectomia, com uma taxa de recidiva em torno de 18%.<sup>(<xref rid="B17" ref-type="bibr">17</xref>,<xref rid="B18" ref-type="bibr">18</xref>)</sup> As met&#xE1;stases &#xE0; dist&#xE2;ncia, de acordo com Schwartz et al.,<sup>(<xref rid="B4" ref-type="bibr">4</xref>) </sup>n&#xE3;o s&#xE3;o descritas sem envolvimento hep&#xE1;tico.</p>
        <p>At&#xE9; o ano de 2009, Lin et al.,<sup>(<xref rid="B8" ref-type="bibr">8</xref>)</sup> na maior casu&#xED;stica da literatura, reportaram 94 casos e evidenciaram dor abdominal como o sintoma mais frequente (presente em 44% dos casos), seguido por massa abdominal (14,3%) e aus&#xEA;ncia de sintomas (13,1%); localiza&#xE7;&#xE3;o unilobar (76,6%) e les&#xE3;o &#xFA;nica (62,8%). A hepatectomia foi realizada 86,8% de seus pacientes, com uma taxa de mortalidade global de 25,5%.</p>
        <p>Huang et al.<sup>(<xref rid="B2" ref-type="bibr">2</xref>)</sup> s&#xE3;o os autores com a maior casu&#xED;stica de um &#xFA;nico servi&#xE7;o, com relato de 11 casos de TNPF em 13 anos de an&#xE1;lise.</p>
      </sec>
      <sec>
        <title>CONCLUS&#xC3;O</title>
        <p>Os tumores carcinoides metast&#xE1;ticos para o f&#xED;gado s&#xE3;o relativamente comuns. Entretanto, o acometimento prim&#xE1;rio desse &#xF3;rg&#xE3;o &#xE9; bastante raro. Necessita-se de melhora nos m&#xE9;todos diagn&#xF3;sticos para que haja uma diferencia&#xE7;&#xE3;o pr&#xE9;-operat&#xF3;ria mais precisa entre tumores neuroend&#xF3;crinos prim&#xE1;rios do f&#xED;gado e carcinoma hepatocelular.</p>
        <p>Pacientes sem um passado de hepatopatia cr&#xF4;nica, com n&#xED;veis normais de alfafetoprote&#xED;na e imagem s&#xF3;lido-c&#xED;stica nos exames de imagem, combinadas com diarreia e dor abdominal, devem ter aventada a hip&#xF3;tese de um caso de tumor neuroend&#xF3;crino prim&#xE1;rio do f&#xED;gado.</p>
      </sec>
    </body>
  </sub-article>
</article>
</pmc-articleset>
